Showing 1 - 13 results of 13 for search '"Gold Four"', query time: 0.25s Refine Results
  1. 1

    The influence of glucocorticoids on the bone tissue in patients with chronic obstructive pulmonary disease by N.P. Masik, O.I. Masik, T.Yu. Niushko

    Published 2024-06-01
    “…Its frequency depended on the stage of COPD: GOLD 3 — in 22.22 % of patients, GOLD 4 — in 50.0 % of the subjects.…”
    Get full text
    Article
  2. 2

    Diagnosis and Severity Assessment of COPD Using a Novel Fast-Response Capnometer and Interpretable Machine Learning by Leeran Talker, Cihan Dogan, Daniel Neville, Rui Hen Lim, Henry Broomfield, Gabriel Lambert, Ahmed Selim, Thomas Brown, Laura Wiffen, Julian Carter, Helen F. Ashdown, Gail Hayward, Elango Vijaykumar, Scott T. Weiss, Anoop Chauhan, Ameera X. Patel

    Published 2024-12-01
    “…A logistic regression model was also trained to distinguish GOLD 1 from GOLD 4 COPD with the output probability used as an index of severity.Results The best diagnostic model achieved an AUROC of 0.890, sensitivity of 0.771, specificity of 0.850 and positive predictive value (PPV) of 0.834. …”
    Get full text
    Article
  3. 3

    Comparison of STAR and GOLD in Assessing Disease Severity Among High-Risk and COPD Patients: Evidence from Enjoying Breathing Program in China by Huang K, Tang X, Chu X, Niu H, Li W, Zheng Z, Peng Y, Lei J, Li Y, Li B, Yang T, Wang C

    Published 2024-12-01
    “…In addition, in COPD patients, by considering of GOLD and STAR together, GOLD 3 and 4 can provide more information about the exacerbation based on each STAR level, and STAR 1 and 2 can provide more information about the exacerbation in GOLD 2– 4. COPD patients with GOLD 4 and STAR 2 (HR=4.08, 95% CI: 2.75– 6.04) had the highest risk of exacerbation, followed by COPD patients with GOLD 4 and STAR 1 (HR=3.94, 95% CI: 2.49– 6.23).Conclusion: In COPD patients, GOLD performs better than STAR in predicting exacerbation risk. …”
    Get full text
    Article
  4. 4

    STIMULASI HASIL MELON ( Cucumis melo, L) DENGAN MENGGUNAKAN BIOTO GROW GOLD (BGG) by SAHINDAH ARITONANG, SURTINAH SURTINAH

    Published 2018-08-01
    “… The experiment was conducted experimentally using non-factorial Randomized Design (RAL) with 5 (five) treatment levels without Bioto Grow Gold, Bioto Grow Gold 1 ml liter-1 water, Bioto Grow Gold 2 ml liter -1 water, giving Bioto Grow Gold 3 ml liter-1 water and giving Bioto Grow Gold 4 ml liter-1 water. The data analysis used variance and continued with a different test of Duncan treatment average at p 0.05. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7

    Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study by Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova

    Published 2024-11-01
    “…A comparative analysis of patients who received inpatient treatment for COPD showed that the frequency of patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) I was half as high after the COVID-19 pandemic, whereas the individuals with GOLD IV were more frequent during the same period (p<0.05). …”
    Get full text
    Article
  8. 8
  9. 9
  10. 10
  11. 11

    Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and After Exacerbation by Mayr W, Triantafyllopoulos A, Batliner A, Schuller BW, Berghaus TM

    Published 2025-01-01
    “…Our baseline for predicting patient state was an SVM model using self-reported BORG and COPD Assessment Test (CAT) scores.Results: In 50 COPD patients (52% males, 22% GOLD II, 44% GOLD III, 32% GOLD IV, all patients group E), speech analysis was superior in distinguishing during and after exacerbation status compared to BORG and CAT scores alone by achieving 84% accuracy in prediction. …”
    Get full text
    Article
  12. 12
  13. 13

    Increased activity reduces the prevalence of woody breast in Ross 708 and Ranger Gold broilers by Cirenio Hisasaga, Maja M. Makagon

    Published 2024-12-01
    “…Both prevalence (Ross 708: 77.5 vs. 90.5% control, P = 0.013; Ranger Gold: 57.9 vs. 76.4% control, P = 0.005) and severity (Ross 708: 12.9 vs. 24.2% control, P = 0.02; Ranger Gold: 4.7 vs. 0.02% control, P = 0.01) were reduced by treatment. …”
    Get full text
    Article